share_log

HC Wainwright & Co. Reiterates Buy on Can Fite Biofarma, Maintains $18 Price Target

HC Wainwright & Co. Reiterates Buy on Can Fite Biofarma, Maintains $18 Price Target

HC Wainwright & Co.重申買入Can Fite Biofarma,維持18美元的目標股價
Benzinga ·  05/09 13:47

HC Wainwright & Co. analyst Vernon Bernardino reiterates Can Fite Biofarma (AMEX:CANF) with a Buy and maintains $18 price target.

HC Wainwright & Co. 分析師弗農·貝納迪諾重申Can Fite Biofarma(AMEX: CANF)的買入並維持18美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論